226 related articles for article (PubMed ID: 6893294)
1. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Casper ES; Gralla RJ; Kelsen DP; Natale RB; Sordillo P; Houghton A
Cancer Treat Rep; 1980; 64(2-3):345-7. PubMed ID: 6893294
[No Abstract] [Full Text] [Related]
2. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Van Echo DA; Markus S; Aisner J; Wiernik PH
Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny N; Lynch G; Wookcock T
Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951
[No Abstract] [Full Text] [Related]
4. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
Currie VE; Howard J; Wittes R
Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
[TBL] [Abstract][Full Text] [Related]
5. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
Sordillo PP; Magill GB; Gralla RJ; Kelsen DP
Am J Clin Oncol; 1982 Jun; 5(3):273-5. PubMed ID: 6896259
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
Schneider RJ; Woodcock TM; Yagoda A
Cancer Treat Rep; 1980 Jan; 64(1):183-5. PubMed ID: 6892892
[No Abstract] [Full Text] [Related]
7. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
[No Abstract] [Full Text] [Related]
8. Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.
Warrell RP; Straus DJ; Young CW
Cancer Treat Rep; 1980; 64(10-11):1157-8. PubMed ID: 6893952
[TBL] [Abstract][Full Text] [Related]
9. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
Sordillo PP; Magill GB; Gralla RJ; Golbey RB
Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
[No Abstract] [Full Text] [Related]
10. Phase II evaluation of AMSA in patients with metastatic lung cancer.
Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
[TBL] [Abstract][Full Text] [Related]
11. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
Woodcock TM; Schneider RJ; Young CW
Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of AMSA in lung cancer.
Samson MK; Fraile RJ; Baker LH; Cummings G; Talley RW
Cancer Treat Rep; 1981; 65(7-8):655-8. PubMed ID: 6265083
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
[TBL] [Abstract][Full Text] [Related]
14. Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas.
Abate G; Villari P; Comella P; D'Aprile M; Castello G; Silvestro P; Zarrilli D; Pergola M
Haematologica; 1985; 70(1):35-8. PubMed ID: 3924754
[No Abstract] [Full Text] [Related]
15. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
Ratanatharathorn V; Drelichman A; Sexon-Porte M; Al-Sarraf M
Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of (m-AMSA) 4'-9-(acridinylamino)-methanesulfon-m-aniside in primary liver cancer.
Cheng E; Lightdale C; Young C; Yagoda A; Fortner J; Golbey R
Am J Clin Oncol; 1983 Apr; 6(2):211-3. PubMed ID: 6299095
[No Abstract] [Full Text] [Related]
17. Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas.
Sternberg CN; Magill GB; Sordillo PP; Cheng E; Currie VE
Am J Clin Oncol; 1983 Aug; 6(4):459-62. PubMed ID: 6688151
[TBL] [Abstract][Full Text] [Related]
18. M-AMSA in disseminated prostatic carcinoma: a phase II study.
Drelichman A; Decker DA; Al-Sarraf M; Dhabuwala CB
Cancer Treat Rep; 1982 Nov; 66(11):1993-4. PubMed ID: 6897206
[No Abstract] [Full Text] [Related]
19. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
Ahmann FR; Meyskens FL; Moon TE; Durie BG; Salmon SE
Cancer Res; 1982 Nov; 42(11):4495-8. PubMed ID: 6897012
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of m-AMSA in patients with small-cell lung cancer.
Natale RB; Gralla RJ; Wittes RE
Cancer Clin Trials; 1981; 4(4):393-5. PubMed ID: 6274533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
